Published in J Mol Biol on May 05, 1976
Radiation damage in macromolecular crystallography: what is it and why should we care? Acta Crystallogr D Biol Crystallogr (2010) 2.82
N-acetyl-beta-D-glucopyranosylamine: a potent T-state inhibitor of glycogen phosphorylase. A comparison with alpha-D-glucose. Protein Sci (1995) 0.90
Solid state 31P cross-polarization/magic angle sample spinning nuclear magnetic resonance of crystalline glycogen phosphorylase b. Biophys J (1993) 0.90
Location of pyridoxal phosphate in glycogen phosphorylase a. Proc Natl Acad Sci U S A (1977) 0.89
Allosteric inhibition of glycogen phosphorylase a by the potential antidiabetic drug 3-isopropyl 4-(2-chlorophenyl)-1,4-dihydro-1-ethyl-2-methyl-pyridine-3,5,6-tricarbo xylate. Protein Sci (1999) 0.80
The binding of D-gluconohydroximo-1,5-lactone to glycogen phosphorylase. Kinetic, ultracentrifugation and crystallographic studies. Biochem J (1991) 0.79
Breaking the low barrier hydrogen bond in a serine protease. Protein Sci (1999) 0.79
Subunit interactions and the allosteric response in phosphorylase. Biophys J (1980) 0.77
Lambda replacement vectors carrying polylinker sequences. J Mol Biol (1983) 32.76
Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A (1993) 10.36
Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev (1998) 5.28
Crystal structure of the kinesin motor domain reveals a structural similarity to myosin. Nature (1996) 4.48
Viral cysteine proteases are homologous to the trypsin-like family of serine proteases: structural and functional implications. Proc Natl Acad Sci U S A (1988) 4.32
A structural role for hormone in the thyroid hormone receptor. Nature (1995) 4.27
Evidence that the N-terminal domain of nonstructural protein NS3 from yellow fever virus is a serine protease responsible for site-specific cleavages in the viral polyprotein. Proc Natl Acad Sci U S A (1990) 4.12
The design plan of kinesin motors. Annu Rev Cell Dev Biol (1997) 3.79
Detection of a trypsin-like serine protease domain in flaviviruses and pestiviruses. Virology (1989) 3.55
Structural clues to prion replication. Science (1994) 3.43
Crystal structure of the motor domain of the kinesin-related motor ncd. Nature (1996) 3.21
Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial. J Clin Oncol (1988) 2.91
Switch-based mechanism of kinesin motors. Nature (2001) 2.86
Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung Cancer Working Cadre. J Natl Cancer Inst (1997) 2.52
Autoimmune aetiology for myasthenic (Eaton-Lambert) syndrome. Lancet (1981) 2.36
Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science (1998) 2.31
Structural changes in glycogen phosphorylase induced by phosphorylation. Nature (1988) 2.16
Perturbation of the secondary structure of the scrapie prion protein under conditions that alter infectivity. Proc Natl Acad Sci U S A (1993) 2.10
Patterns of failure following loco-regional radiotherapy in the treatment of limited stage small cell lung cancer. Int J Radiat Oncol Biol Phys (1994) 2.01
Direction determination in the minus-end-directed kinesin motor ncd. Nature (1998) 1.96
Molecular analysis of GPH1, the gene encoding glycogen phosphorylase in Saccharomyces cerevisiae. Mol Cell Biol (1989) 1.92
Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer. J Clin Oncol (1990) 1.88
The three-dimensional structure of Asn102 mutant of trypsin: role of Asp102 in serine protease catalysis. Science (1987) 1.87
Clathrin self-assembly is mediated by a tandemly repeated superhelix. Nature (1999) 1.84
High-resolution chromosome sorting and DNA spot-blot analysis assign McArdle's syndrome to chromosome 11. Science (1984) 1.80
A model for the microtubule-Ncd motor protein complex obtained by cryo-electron microscopy and image analysis. Cell (1997) 1.79
Nuclear-receptor ligands and ligand-binding domains. Annu Rev Biochem (1999) 1.70
The family of glycogen phosphorylases: structure and function. Crit Rev Biochem Mol Biol (1989) 1.70
Turn prediction in proteins using a pattern-matching approach. Biochemistry (1986) 1.65
Hydrogen bonds involving sulfur atoms in proteins. Proteins (1991) 1.58
The influence of disclosure of HIV diagnosis on time to disease progression in a cohort of Romanian children and teens. AIDS Care (2007) 1.49
The crystal structure of cruzain: a therapeutic target for Chagas' disease. J Mol Biol (1995) 1.49
Selective alteration of substrate specificity by replacement of aspartic acid-189 with lysine in the binding pocket of trypsin. Biochemistry (1987) 1.48
A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides. Eur J Immunol (1993) 1.48
The structures and related functions of phosphorylase a. Annu Rev Biochem (1980) 1.48
Evolution of a bifunctional enzyme: 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. Proc Natl Acad Sci U S A (1989) 1.47
X-ray diffraction of scrapie prion rods and PrP peptides. J Mol Biol (1995) 1.47
Three-dimensional structure of a tubulin-motor-protein complex. Nature (1995) 1.46
High resolution x-ray structure of yeast hexokinase, an allosteric protein exhibiting a non-symmetric arrangement of subunits. J Mol Biol (1976) 1.45
Structural basis for the activation of glycogen phosphorylase b by adenosine monophosphate. Science (1991) 1.44
The case for a common ancestor: kinesin and myosin motor proteins and G proteins. J Muscle Res Cell Motil (1998) 1.44
Small cell carcinoma of the bladder: long term outcome with integrated chemoradiation. Cancer (1999) 1.43
Product binding and role of the C-terminal region in class I D-fructose 1,6-bisphosphate aldolase. Nat Struct Biol (1997) 1.42
Superiority of alternating non-cross-resistant chemotherapy in extensive small cell lung cancer. A multicenter, randomized clinical trial by the National Cancer Institute of Canada. Ann Intern Med (1987) 1.38
Parental influences on students' aggressive behaviors and weapon carrying. Health Educ Behav (1999) 1.37
Proposed three-dimensional structure for the cellular prion protein. Proc Natl Acad Sci U S A (1994) 1.35
Demyelinating neuropathy and monoclonal IgM antibody to myelin-associated glycoprotein. Neurology (1983) 1.33
Crescentic glomerulonephritis: a possible complication of streptokinase treatment for myocardial infarction. Br Heart J (1986) 1.33
Dissemination and adoption of the Child and Adolescent Trial for Cardiovascular Health (CATCH): a case study in Texas. J Public Health Manag Pract (2001) 1.32
Crystal structure of a catalytic antibody with a serine protease active site. Science (1994) 1.29
Lambda phage vectors--EMBL series. Methods Enzymol (1987) 1.28
Kinetics of purified liver phosphorylase. J Biol Chem (1966) 1.26
Production of crystallizable cruzain, the major cysteine protease from Trypanosoma cruzi. J Biol Chem (1993) 1.26
Characterization of the catalytic residues of the tobacco etch virus 49-kDa proteinase. Virology (1989) 1.25
Gemcitabine: a promising new agent in the treatment of advanced urothelial cancer. J Clin Oncol (1997) 1.25
Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised. J Exp Med (1995) 1.25
Structural determinants of specificity in the cysteine protease cruzain. Protein Sci (1997) 1.24
Purification and Characterization of Three Chitosanase Activities from Bacillus megaterium P1. Appl Environ Microbiol (1990) 1.23
Perturbing the polar environment of Asp102 in trypsin: consequences of replacing conserved Ser214. Biochemistry (1992) 1.22
Peripheral neuropathy associated with monoclonal IgM autoantibody. Ann Neurol (1987) 1.20
Parallel evolution in two homologues of phosphorylase. Nat Struct Biol (1994) 1.19
Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk. Ann Oncol (2009) 1.19
Selective modulation of thyroid hormone receptor action. J Steroid Biochem Mol Biol (2001) 1.18
Novel active site in Escherichia coli fructose 1,6-bisphosphate aldolase. Nat Struct Biol (1996) 1.17
Hormone selectivity in thyroid hormone receptors. Mol Endocrinol (2001) 1.17
The structure of a yeast hexokinase monomer and its complexes with substrates at 2.7-A resolution. Proc Natl Acad Sci U S A (1975) 1.17
Non-risk-adapted surveillance for patients with stage I nonseminomatous testicular germ-cell tumors: diminishing treatment-related morbidity while maintaining efficacy. Ann Oncol (2009) 1.16
The sequence and reactive site of ecotin. A general inhibitor of pancreatic serine proteases from Escherichia coli. J Biol Chem (1991) 1.15
PRISM: topologically constrained phased refinement for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr (1993) 1.14
Human muscle glycogen synthase cDNA sequence: a negatively charged protein with an asymmetric charge distribution. Proc Natl Acad Sci U S A (1989) 1.14
Crystal structure of the hypoxanthine-guanine-xanthine phosphoribosyltransferase from the protozoan parasite Tritrichomonas foetus. Biochemistry (1996) 1.13
Sequence analysis of the cDNA encoding human liver glycogen phosphorylase reveals tissue-specific codon usage. Proc Natl Acad Sci U S A (1986) 1.13
The structure of glycogen phosphorylase alpha at 2.5 A resolution. J Mol Biol (1979) 1.13
High resolution crystal structures of yeast hexokinase complexes with substrates, activators, and inhibitors. Evidence for an allosteric control site. J Biol Chem (1977) 1.12
Structure-based design of parasitic protease inhibitors. Bioorg Med Chem (1996) 1.12
Covalent intermediate trapped in 2-keto-3-deoxy-6- phosphogluconate (KDPG) aldolase structure at 1.95-A resolution. Proc Natl Acad Sci U S A (2001) 1.11
Outcome evaluation of a multi-component violence-prevention program for middle schools: the Students for Peace project. Health Educ Res (2000) 1.11
Purification and characterization of thermostable beta-mannanase and alpha-galactosidase from Bacillus stearothermophilus. Appl Environ Microbiol (1990) 1.11
Convergent and divergent evolution of regulatory sites in eukaryotic phosphorylases. Nature (1986) 1.11
Human monoclonal antibodies to myelin-associated glycoprotein. Comparison of specificity and use for immunocytochemical localisation of the antigen. J Neuroimmunol (1983) 1.10
A natural transactivation mutation in the thyroid hormone beta receptor: impaired interaction with putative transcriptional mediators. Proc Natl Acad Sci U S A (1997) 1.10
A retrospective mortality study within operating segments of a petroleum company. Am J Ind Med (1992) 1.10
X-ray crystallographic and kinetic studies of oligosaccharide binding to phosphorylase. J Biol Chem (1978) 1.10
Human brain glycogen phosphorylase. Cloning, sequence analysis, chromosomal mapping, tissue expression, and comparison with the human liver and muscle isozymes. J Biol Chem (1988) 1.09
A protein phosphorylation switch at the conserved allosteric site in GP. Science (1996) 1.08
The role of prophylactic brain irradiation in limited stage small cell lung cancer: clinical, neuropsychologic, and CT sequelae. Int J Radiat Oncol Biol Phys (1988) 1.08
Secondary structure assignment for alpha/beta proteins by a combinatorial approach. Biochemistry (1983) 1.08
Relocating a negative charge in the binding pocket of trypsin. J Mol Biol (1993) 1.08
Catalytic site of glycogen phosphorylase: structural changes during activation and mechanistic implications. Biochemistry (1982) 1.08
A target within the target: probing cruzain's P1' site to define structural determinants for the Chagas' disease protease. Structure (2000) 1.08
Molecular and structural biology of thyroid hormone receptors. Clin Exp Pharmacol Physiol Suppl (1998) 1.06
Dose-intensity meta-analysis of chemotherapy regimens in small-cell carcinoma of the lung. J Clin Oncol (1991) 1.06
Reassessment of the catalytic mechanism of glycogen debranching enzyme. Biochemistry (1991) 1.05